FBRC partnered with the Postgraduate Program at Padjadjaran University by collaborating with a Master’s student
BANDUNG – FBRC partnered with the Postgraduate Program at Padjadjaran University by collaborating with a Master’s student, Zidni Muflikhati, in the Biotechnology Study Program, UNPAD, under the direction of Ir. Anas, M.Sc., Ph.D. and Dr. Nesti F. Sianipar, SP., M.Si to develop the ARMS-PCR marker to identify the lectin gene. Ir. Anas, M.Sc., Ph.D. provided critical insights into the experimental design, ensuring the accuracy and reliability of the ARMS-PCR marker. Dr. Nesti F. Sianipar, SP., M.Si contributed her expertise in methodology, data analysis, and interpretation, enhancing the overall understanding of the lectin gene. As part of the Amplification Refractory Mutation System PCR (ARMS-PCR), Tetra Primer ARMS-PCR can detect various types of variations in genes. This includes mutations associated with cancer and other serious diseases. Zidni defended her thesis at Unpad, Bandung on Wednesday (07/08/2024) in front of supervisors and examiners. One of the significant challenges Zidni faced during her research was optimizing the primer design to ensure specificity and efficiency. Additionally, she had to troubleshoot various PCR conditions to achieve consistent results. Despite these difficulties, her perseverance and innovative approach led successful identification of the lectin gene SNAP. In order to improve this research plan, it was discussed how important it is to design primers carefully to ensure accurate results. A researcher must always consider emerging results when selecting methods, designing experiments, and selecting primary designs. The research collaboration represents an important step toward combining expertise, resources, and knowledge. This research collaboration could lead to significant advancements in cancer treatment by identifying and harnessing anticancer compounds from genes of rodent tuber mutant plants. Additionally, it opens the information for further genetic studies that could revolutionize our understanding of gene variations and their roles in the pathway of anticancer compounds. By combining expertise from various fields, this partnership enhances the potential for innovative solutions and breakthrough discoveries in biotechnology.
Comments :